Position in AMRX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$1,552,482
+$577,230 QoQ
Shares Held
124,898
+61.4% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JENNISON ASSOCIATES LLC holds $132,527,619 across 5 Drug Manufacturers - Specialty & Generic names. AMRX ranks #4 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
3,120,665 | $74,677,512 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,439,151 | $43,347,228 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
207,096 | $12,274,579 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
124,898 | $1,552,482 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
20,436 | $675,818 |
All Filings in AMRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,552,482 | 124,898 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $975,252 | 77,401 | Shares | Defined | 2026-01-30 | |
| 2025-06-30 | $635,453 | 78,548 | Shares | Defined | 2025-08-01 | |
| 2025-03-31 | $598,549 | 71,426 | Shares | Defined | 2025-05-05 | |
| No filing history on record for this holder in this stock. | ||||||